{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:03:21Z","timestamp":1783483401331,"version":"3.55.0"},"reference-count":30,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1507\/endocrj.k10e-262","type":"journal-article","created":{"date-parts":[[2010,12,28]],"date-time":"2010-12-28T05:20:22Z","timestamp":1293513622000},"page":"95-100","source":"Crossref","is-referenced-by-count":45,"title":["Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission"],"prefix":"10.1507","volume":"58","author":[{"given":"Toshiaki","family":"Konishi","sequence":"first","affiliation":[{"name":"Sumire Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Sumire Clinic, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Ueda","sequence":"additional","affiliation":[{"name":"Sumire Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Sumire Clinic, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiko","family":"Harusato","sequence":"additional","affiliation":[{"name":"Sumire Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Sumire Clinic, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Hamada","sequence":"additional","affiliation":[{"name":"Sumire Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1989.tb01244.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Badenhoop K, Hensen J, Finke R, Bogner U, Mayr WR et al (1989) Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves&rsquo; disease. <i>Acta Endocrinol (Copenh)<\/i> 120: 689-701.","DOI":"10.1530\/acta.0.1200689"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi R, Martino E, Pinchera A (1997) Clinical features of patients with Graves&rsquo; disease undergoing remission after antithyroid drug treatment. <i>Thyroid<\/i> 7: 369-375.","DOI":"10.1089\/thy.1997.7.369"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.273.10.808"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN (1996) Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. <i>BMJ<\/i> 313: 539-544.","DOI":"10.1136\/bmj.313.7056.539"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL; American Association of Clinical Endocrinologists. (2002) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. <i>Endocr Pract<\/i> 8: 457-469.","DOI":"10.4158\/1934-2403-8.6.457"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00629.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y, Izumi M. (1991) Differences and similarities in the diagnosis and treatment of Graves&rsquo; disease in Europe, Japan, and the United States. <i>Thyroid<\/i> 1: 129-135.","DOI":"10.1089\/thy.1991.1.129"},{"key":"9","unstructured":"9. Glinoer D, Hesch D, Lagasse R, Laurberg P (1987) The management of hyperthyroidism due to Graves&rsquo; disease in Europe in 1986. Results of an international survey. <i>Acta Endocrinol (Copenh)<\/i> 285(Suppl): 3-23."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamamoto M, Totsuka Y, Kojima I, Yamashita N, Togawa K, Sawaki N, Ogata E (1983) Outcome of patients with Graves&rsquo; disease after long-term medical treatment guided by triiodothyronine (T3) suppression test.<i> Clin Endocrinol (Oxf)<\/i> 19: 467-476.","DOI":"10.1111\/j.1365-2265.1983.tb00021.x"},{"key":"11","unstructured":"11. Takasu N, Akamine H, Komiya I, Yamada T (1995) Simple and reliable method for predicting the remission of Graves&rsquo; disease: revised triiodothyronine-suppression test, indexed by serum thyroxine. <i>J Endocrinol Invest.<\/i> 18: 288-294."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dahlberg PA, Karlsson FA, Jansson R, Wide L (1985) Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves&rsquo; disease as an indicator of remission. <i>J Clin Endocrinol Metab<\/i> 61: 1100-1104.","DOI":"10.1210\/jcem-61-6-1100"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Notsu K, Oka N, Masaki Y, Furuya H, Kato Y (1991) Plasma tree triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves&rsquo; disease treated with antithyroid drugs. <i>J Clin Endocrinol Metab<\/i> 73: 396-400.","DOI":"10.1210\/jcem-73-2-396"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Takamatsu J, Kuma K, Mozai T (1986) Serum triiodothyronine to thyroxine ratio: A newly recognized predictor of the outcome of hyperthyroidism due to Graves&rsquo; disease. <i>J Clin Endocrinol Metab<\/i> 62: 980-983.","DOI":"10.1210\/jcem-62-5-980"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kawamura S, Kishino B, Tajima K, Mashita K, Tarui S (1983) Serum thyroglobulin changes in patients with Graves&rsquo; disease treated with long term antithyroid drug therapy. <i>J Clin Endocrinol Metab<\/i> 56: 507-512.","DOI":"10.1210\/jcem-56-3-507"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Talbot JN, Duron F, Feron R, Aubert P, Milhaud G (1989) Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves&rsquo; disease within one year. <i>J Endocrinol Invest<\/i> 12: 589-595.","DOI":"10.1007\/BF03350008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chowdhury TA, Dyer PH (1998) Clinical, biochemical and immunological characteristics of relapsers and non-relapsers of thyrotoxicosis treated with anti-thyroid drugs.<i> J Intern Med<\/i> 244: 293-297.","DOI":"10.1046\/j.1365-2796.1998.00320.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Winsa B, Dahlberg A, Jansson R, Agren H, Karlsson FA (1990) Factors influencing the outcome of thyrostatic drug therapy in Graves&rsquo; disease. <i>Acta Endocrinol (Copenh)<\/i> 122: 722-728.","DOI":"10.1530\/acta.0.1220722"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Michelangeli V, Poon C, Taft J, Newnham H, Topliss D, Colman P (1998) The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves&rsquo; disease with antithyroid drugs. <i>Thyroid<\/i> 8: 119-124.","DOI":"10.1089\/thy.1998.8.119"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A (2000) Remission of Graves&rsquo; hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment. <i>Thyroid<\/i> 10: 891-896.","DOI":"10.1089\/thy.2000.10.891"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-814217"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K06-069"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.1.98"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02919.x"},{"key":"25","unstructured":"25. Guideline for the treatment of Graves&rsquo; disease with antithyrid drug in Japan. The Japan Thyroid Association, 2006, Nankodo Co., Ltd., Tokyo."},{"issue":"2","key":"26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1507\/endocrj1954.38.223","volume":"38","author":"TAJIRI J","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7219","issn-type":"print"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K05-121"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.50.45"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.44.553"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Laurberg P (2006) Remission of Graves&rsquo; disease during anti-thyroid drug therapy. Time to reconsider the mechanism? <i>Eur J Endocrinol<\/i> 155: 783-786.","DOI":"10.1530\/eje.1.02295"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/2\/58_K10E-262\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:54:49Z","timestamp":1618296889000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/2\/58_K10E-262\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k10e-262","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}